Employees: 1,694
Size Jianerkang Medical (603205.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $487M, the 3917th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥21.15 on 6 Nov 2026.
Performance Over six months the shares fell 18.8%, against -5.4% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue fell 2.0% over the last twelve months (peer median +5.5%); the operating margin is 13.7% (peer median 7.6%).
Valuation It trades at 2.3× enterprise value to sales against a peer median of 2.9× (9th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is -9%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 13.1 points above its cost of capital (5.1% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.10B | CN¥1.02B | CN¥1.04B | CN¥1.03B | CN¥1.09B |
| Revenue growth | — | -2% | +1% | -5% | — |
| Gross profit | CN¥313M | CN¥238M | CN¥229M | CN¥226M | CN¥254M |
| EBITDA | n/a | CN¥169M | CN¥165M | CN¥132M | CN¥148M |
| Net income | CN¥123M | CN¥111M | CN¥120M | CN¥124M | CN¥157M |
| Free cash flow | CN¥92.3M | CN¥90.3M | CN¥102M | CN¥73.6M | CN¥96.8M |
| Capital expenditure | CN¥101M | CN¥70.0M | CN¥39.7M | CN¥84.2M | CN¥66.3M |
| Total debt | CN¥18.0M | CN¥21.8M | CN¥0 | CN¥0 | CN¥30.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 603205.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.6% | -2.1% | 11th highest of 21 |
| 6-month return | -18.8% | -5.4% | 7th lowest of 21 |
| Distance from 52-week high | -31.9% | -26.4% | 10th lowest of 21 |
| Revenue growth (TTM) | -2.0% | +5.5% | 4th lowest of 21 |
| Operating margin | 13.7% | 7.6% | 9th highest of 21 |
| EV / Sales | 2.3× | 2.9× | 9th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | -2.9% | 2.1% | 6th least demanding of 14 |
| Growth delivered (Del g) | -8.8% | +18.3% | lowest of 14 |
| Hurdle (Req g minus delivered) | +5.9 pp | -13.7 pp | 2nd most demanding of 14 |
| ROIC minus cost of capital | +13.1 pp | +1.3 pp | 3rd highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jianerkang Medical 603205.SS | China | $487M | -19% | -2% | 14% | 2.3× | -2.9% | -8.8% |
| GPI GPI.MI | Italy | $487M | -3% | +2% | 6% | 1.6× | n/a | n/a |
| Mitsubishi Research Institute 3636.T | Japan | $489M | +8% | +4% | 7% | 0.4× | -9.9% | +4.1% |
| C.E. Info Systems MAPMYINDIA.NS | India | $486M | -13% | +3% | 31% | 8.1× | 31.1% | +25.5% |
| LINE Pay Taiwan 7722.TW | Taiwan | $484M | -16% | +20% | 6% | n/a | n/a | n/a |
| Shenzhen Water Planning & Design Institute 301038.SZ | China | $484M | -26% | +6% | 8% | 3.2× | 20.2% | -1.9% |
| eGuarantee 8771.T | Japan | $482M | -5% | +5% | 48% | 5.8× | -6.7% | +8.3% |
| Hunan Airbluer Environmental Protection Technology 301259.SZ | China | $498M | -47% | -43% | -17% | 23.1× | n/a | n/a |
| Coor Service Management COOR.ST | Sweden | $475M | -16% | -1% | 5% | 0.6× | -8.2% | +5.4% |
| Hangzhou Landscape Architecture Design Institute 300649.SZ | China | $473M | +24% | -24% | -39% | 24.6× | n/a | n/a |
| Shanghai Model Organisms Center 688265.SS | China | $503M | +7% | +14% | -1% | 5.5× | n/a | n/a |
| Anhui Guqi Down and Feather Textile 001390.SZ | China | $472M | -26% | +9% | 16% | 3.1× | n/a | n/a |
| MHA MHA.L | United Kingdom | $504M | -4% | +12% | 15% | 1.5× | -15.0% | +30.6% |
| Italian Exhibition IEG.MI | Italy | $505M | +14% | +4% | 18% | 2.1× | -4.8% | +28.4% |
| Diversified Royalty DIV.TO | Canada | $507M | -6% | +15% | 86% | 17.9× | 13.0% | +18.3% |
| Gabia 079940.KS | South Korea | $468M | +64% | +12% | 14% | 2.6× | 1.0% | +14.7% |
| Pony Testing 300887.SZ | China | $513M | -35% | -2% | -12% | 2.1× | n/a | n/a |
| Western Regions Tourism Development 300859.SZ | China | $513M | -30% | -13% | 15% | 12.0× | 38.8% | +44.7% |
| Medley 4480.T | Japan | $463M | +2% | +24% | 8% | 1.9× | 16.0% | +40.0% |
| adesso ADN1.DE | Germany | $513M | +31% | +13% | 4% | 0.5× | 2.1% | +22.9% |
| Shenzhen Tiansu Calibration & Testing 301449.SZ | China | $462M | -30% | +8% | 10% | 2.9× | 11.1% | +13.2% |